CN1844144A - 一种高生物活性卵黄抗体的制备方法 - Google Patents
一种高生物活性卵黄抗体的制备方法 Download PDFInfo
- Publication number
- CN1844144A CN1844144A CN 200610040414 CN200610040414A CN1844144A CN 1844144 A CN1844144 A CN 1844144A CN 200610040414 CN200610040414 CN 200610040414 CN 200610040414 A CN200610040414 A CN 200610040414A CN 1844144 A CN1844144 A CN 1844144A
- Authority
- CN
- China
- Prior art keywords
- yolk
- antibody
- egg
- yolk antibody
- filtration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 70
- 238000000034 method Methods 0.000 claims abstract description 30
- 239000012528 membrane Substances 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 17
- 230000004071 biological effect Effects 0.000 claims abstract description 15
- 238000005516 engineering process Methods 0.000 claims abstract description 12
- 239000006227 byproduct Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims description 23
- 102000002322 Egg Proteins Human genes 0.000 claims description 16
- 108010000912 Egg Proteins Proteins 0.000 claims description 16
- 238000000108 ultra-filtration Methods 0.000 claims description 16
- 235000013601 eggs Nutrition 0.000 claims description 15
- 239000000287 crude extract Substances 0.000 claims description 12
- 239000003292 glue Substances 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 238000001471 micro-filtration Methods 0.000 claims description 10
- 229920005615 natural polymer Polymers 0.000 claims description 10
- 230000036039 immunity Effects 0.000 claims description 8
- 229960005486 vaccine Drugs 0.000 claims description 8
- 230000001717 pathogenic effect Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 6
- 235000014103 egg white Nutrition 0.000 claims description 6
- 210000000969 egg white Anatomy 0.000 claims description 6
- 235000013345 egg yolk Nutrition 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 5
- 159000000007 calcium salts Chemical class 0.000 claims description 5
- 230000003053 immunization Effects 0.000 claims description 5
- 238000002649 immunization Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 210000004681 ovum Anatomy 0.000 claims description 4
- 244000052769 pathogen Species 0.000 claims description 4
- 229920002492 poly(sulfone) Polymers 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 229940005550 sodium alginate Drugs 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 241000590002 Helicobacter pylori Species 0.000 claims description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 3
- 241000607142 Salmonella Species 0.000 claims description 3
- 241000194019 Streptococcus mutans Species 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 235000011086 calcium lactate Nutrition 0.000 claims description 3
- 239000001527 calcium lactate Substances 0.000 claims description 3
- 229960002401 calcium lactate Drugs 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 210000001072 colon Anatomy 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 229940037467 helicobacter pylori Drugs 0.000 claims description 3
- 239000000568 immunological adjuvant Substances 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 210000000214 mouth Anatomy 0.000 claims description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 239000002033 PVDF binder Substances 0.000 claims description 2
- 241000978776 Senegalia senegal Species 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical group [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 2
- 239000001639 calcium acetate Substances 0.000 claims description 2
- 235000011092 calcium acetate Nutrition 0.000 claims description 2
- 229960005147 calcium acetate Drugs 0.000 claims description 2
- 229960002713 calcium chloride Drugs 0.000 claims description 2
- 235000011148 calcium chloride Nutrition 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 230000002906 microbiologic effect Effects 0.000 claims description 2
- 229920006393 polyether sulfone Polymers 0.000 claims description 2
- 230000009257 reactivity Effects 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 abstract description 7
- 238000002955 isolation Methods 0.000 abstract description 2
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 9
- 230000008569 process Effects 0.000 description 7
- 235000020256 human milk Nutrition 0.000 description 5
- 210000004251 human milk Anatomy 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 102000010445 Lactoferrin Human genes 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 235000021242 lactoferrin Nutrition 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610040414A CN100575362C (zh) | 2006-05-08 | 2006-05-08 | 一种高生物活性卵黄抗体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610040414A CN100575362C (zh) | 2006-05-08 | 2006-05-08 | 一种高生物活性卵黄抗体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1844144A true CN1844144A (zh) | 2006-10-11 |
CN100575362C CN100575362C (zh) | 2009-12-30 |
Family
ID=37063114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610040414A Expired - Fee Related CN100575362C (zh) | 2006-05-08 | 2006-05-08 | 一种高生物活性卵黄抗体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100575362C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102308914A (zh) * | 2011-07-25 | 2012-01-11 | 大连赛姆生物工程技术有限公司 | 一种动物食疗性卵黄抗体全蛋液膏状制剂及其制备方法 |
WO2012016429A1 (en) * | 2010-08-03 | 2012-02-09 | Asia Hepato Gene Co. | Compositions and methods for treating hepatitis virus infection |
CN102516389A (zh) * | 2011-12-28 | 2012-06-27 | 黑龙江省农业科学院畜牧研究所 | 一种提取禽流感卵黄抗体的方法 |
CN103709247A (zh) * | 2013-12-30 | 2014-04-09 | 哈药集团生物疫苗有限公司 | 一种ⅰ型、新型鸭肝炎二价卵黄抗体的制备方法及其产品和应用 |
CN104045708A (zh) * | 2014-05-14 | 2014-09-17 | 安徽林苑农副食品有限公司 | 一种利用鸡蛋制作免疫球蛋白的方法 |
CN107043415A (zh) * | 2017-03-07 | 2017-08-15 | 尤丽康(江苏)生物医药有限公司 | 一种卵黄免疫球蛋白的提取方法 |
CN107383189A (zh) * | 2017-08-11 | 2017-11-24 | 山东阿斯可来生物技术有限公司 | 卵黄抗体干燥粉制备的方法 |
CN110627899A (zh) * | 2019-10-09 | 2019-12-31 | 山东天牧生物科技有限公司 | 一种呼肠孤病毒和细小病毒卵黄抗体锭及其制备方法 |
CN111718410A (zh) * | 2020-06-05 | 2020-09-29 | 江南大学 | 一种制备卵黄免疫球蛋白的方法 |
CN112048533A (zh) * | 2020-09-21 | 2020-12-08 | 青岛润达生物科技有限公司 | 一种高效抗体粉的制备方法 |
-
2006
- 2006-05-08 CN CN200610040414A patent/CN100575362C/zh not_active Expired - Fee Related
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102884079B (zh) * | 2010-08-03 | 2014-12-10 | 华肝基因股份有限公司 | 治疗肝炎病毒感染的组合物及方法 |
WO2012016429A1 (en) * | 2010-08-03 | 2012-02-09 | Asia Hepato Gene Co. | Compositions and methods for treating hepatitis virus infection |
CN102884079A (zh) * | 2010-08-03 | 2013-01-16 | 华肝基因股份有限公司 | 治疗肝炎病毒感染的组合物及方法 |
CN102308914A (zh) * | 2011-07-25 | 2012-01-11 | 大连赛姆生物工程技术有限公司 | 一种动物食疗性卵黄抗体全蛋液膏状制剂及其制备方法 |
CN102516389A (zh) * | 2011-12-28 | 2012-06-27 | 黑龙江省农业科学院畜牧研究所 | 一种提取禽流感卵黄抗体的方法 |
CN103709247A (zh) * | 2013-12-30 | 2014-04-09 | 哈药集团生物疫苗有限公司 | 一种ⅰ型、新型鸭肝炎二价卵黄抗体的制备方法及其产品和应用 |
CN103709247B (zh) * | 2013-12-30 | 2016-02-10 | 哈药集团生物疫苗有限公司 | 一种ⅰ型、新型鸭肝炎二价卵黄抗体的制备方法及其产品和应用 |
CN104045708A (zh) * | 2014-05-14 | 2014-09-17 | 安徽林苑农副食品有限公司 | 一种利用鸡蛋制作免疫球蛋白的方法 |
CN107043415A (zh) * | 2017-03-07 | 2017-08-15 | 尤丽康(江苏)生物医药有限公司 | 一种卵黄免疫球蛋白的提取方法 |
CN107383189A (zh) * | 2017-08-11 | 2017-11-24 | 山东阿斯可来生物技术有限公司 | 卵黄抗体干燥粉制备的方法 |
CN110627899A (zh) * | 2019-10-09 | 2019-12-31 | 山东天牧生物科技有限公司 | 一种呼肠孤病毒和细小病毒卵黄抗体锭及其制备方法 |
CN111718410A (zh) * | 2020-06-05 | 2020-09-29 | 江南大学 | 一种制备卵黄免疫球蛋白的方法 |
CN111718410B (zh) * | 2020-06-05 | 2022-10-11 | 江南大学 | 一种制备卵黄免疫球蛋白的方法 |
CN112048533A (zh) * | 2020-09-21 | 2020-12-08 | 青岛润达生物科技有限公司 | 一种高效抗体粉的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100575362C (zh) | 2009-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100575362C (zh) | 一种高生物活性卵黄抗体的制备方法 | |
DK202100114Y4 (da) | Separation af 2’-FL fra en fermentationskulturopløsning | |
CN101974589B (zh) | 一种酶解和膜分离制备免疫活性大豆肽的方法 | |
CN102154163A (zh) | 一种3′-唾液酸乳糖的制备方法 | |
CN103160482B (zh) | 一种共分离制备鸡蛋清溶菌酶与活性蛋白的方法 | |
JPWO2009008362A1 (ja) | シアル酸化合物含有組成物の製造方法 | |
JPH07502889A (ja) | 初乳フラクション、その製造方法および細胞培養培地補充物質としてのその使用方法 | |
CN111718410B (zh) | 一种制备卵黄免疫球蛋白的方法 | |
CN105218666A (zh) | 一种采用阳离子多糖制备高生物活性卵黄抗体的方法 | |
CN1129609C (zh) | 一种絮凝澄清-超滤浓缩工艺生产复合免疫活性蛋白的方法 | |
CN103642853A (zh) | 一种l-苹果酸提取新工艺 | |
CN101380469A (zh) | 大菱鲆红体病虹彩病毒灭活疫苗的生产工艺 | |
IE47149B1 (en) | Vaccine | |
JP3929085B2 (ja) | ガングリオシド高含有組成物の製造法 | |
WO2023221758A1 (zh) | 三糖的新晶型 | |
CN106866817A (zh) | 一种提取鸭坦布苏病毒病卵黄抗体的工艺方法 | |
CN108728375B (zh) | 奶牛瘤胃菌群的体外培养及保存方法 | |
CN1629183A (zh) | 从牦牛奶中提取的活性乳蛋白及其方法和应用 | |
CN1288169C (zh) | 海参粘多糖的制备方法 | |
CN104558225B (zh) | 一种针对肠道细菌的荚膜多糖提取方法 | |
CN1478422A (zh) | 富含海参粘多糖食品及其制备方法 | |
JP4980942B2 (ja) | 卵黄タンパク質の製造法 | |
CN107674898A (zh) | 一种由维生素k2发酵液中提取蛋白质的方法 | |
CN101040632B (zh) | 抗阪歧肠杆菌特异性免疫奶制品及其制备方法 | |
CN1137269C (zh) | 一种海产小杂鱼提取物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU KANGDE EGG INDUSTRY CO., LTD. Free format text: FORMER OWNER: JIANGNAN UNIVERSITY Effective date: 20150420 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 214036 WUXI, JIANGSU PROVINCE TO: 226600 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150420 Address after: 226600, No. 199, Yao Middle Road, Haian County Development Zone, Nantong County, Jiangsu, China Patentee after: JIANGSU KANGDE EGGS Co.,Ltd. Address before: 214036 Jiangsu city of Wuxi Province River Road No. 170 Patentee before: Jiangnan University |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20061011 Assignee: Guangdong Beijing Hao pharmaceutical science and technology development Co. Assignor: JIANGSU KANGDE EGGS Co.,Ltd. Contract record no.: 2015440000685 Denomination of invention: Process for preparing yelk antibody with high bioactivity Granted publication date: 20091230 License type: Common License Record date: 20151016 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20170908 Contract record no.: 2015440000685 Assignee after: Guangdong Beijing Hao Biological Pharmaceutical Co.,Ltd. Assignee before: Guangdong Beijing Hao pharmaceutical science and technology development Co. |
|
EM01 | Change of recordation of patent licensing contract | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091230 |